Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Sydromes in China (CPACS) study. American Heart Journal. 2009; 157:509-516. .
Gaps in cardiovascular disease risk management in Australian general practice. Medical Journal of Australia. 2009;191:324-9..
How to Treat – Cardiovascular Disease Risk Assessment. Australian Doctor. 2009:25-31..
Impact of glucose control on macrovascular and microvascular disease: insights from ADVANCE. In: American Heart Association Scientific Sessions. American Heart Association Scientific Sessions. Orlando, US; 2009..
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288-98.
[Letter to the Editor] ADVANCE Blood pressure lowering in diabetes. Journal of Clinical Hypertension (Greenwich). 2009;11:108..
Management of cardiovascular risk factors in Australian General Practice of those at highest risk. Australasian Epidemiologist. 2009;16:6-11. ..
Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (August 2009). 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. 2009;18(Suppl 3):S280.
Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (September 2009). 6th Asia Pacific Conference Against Stroke. 2009.
Re-calibration of a Framingham Risk Equation for a Rural Population in India. Journal of Epidemiology and Community Health. 2009;63:379-85 ..
[Review] Trials of cardiovascular risk management in diabetes. Current Opinion in Cardiology. 2009;24:288-94. ..
Risk of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and artrial fibrillation – results of the ADVANCE study. European Heart Journal. 2009;30 :1128-35.
Routine blood pressure lowering and intensive glucose control in patients with type 2 diabetes: results from the ADVANCE trial. Expert Reviews in Endocrinology & Metabolism. 2009;4:111-18. ..
Routine blood pressure lowering and kidney disease in type 2 diabetes. Journal of the American Society of Nephrology. 2009;20:883-92. .
Smoking, diabetes and cardiovascular diseases in men in the Asia-Pacific Region. Journal of Diabetes. 2009;1:173-81. .
Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal. 2009; 157:436-441. .
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Annals of Internal Medicine. 2009;151:631-8.
ADVANCES in reducing the burden of vascular disease in type 2 diabetes. Clinical and Experimental Pharmacology and Physiology. 2008;35:434-7..
Assessing and delivering cardiovascular health care in Asia. In: 3rd International Conference on Asian Health and Wellbeing. 3rd International Conference on Asian Health and Wellbeing. Auckland, New Zealand: Centre for Asian Health Research and Evaluation; 2008..
Body mass index is an independent determinant of left atrial size. Heart, Lung and Circulation. 2008;17:19-24..
Cardiovascular risk management at a Maori-led Primary Health Organisation - findings from a cross sectional audit. New Zealand Medical Journal. 2008;121:35-46.
Determinants of diabetes mellitus and cardiovascular diseases in the Asia Pacific region. International Diabetes Federation – Western Pacific Forum. 2008;79(Suppl 1)S7..
Effects of blood pressure lowering on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Proceedings of the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) . 2008;51(Suppl 1):S476-S476.
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of evidence available in 2007. Journal of Hypertension. 2008;26 :S21-S27. .
Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region. European Journal of Cardiovascular Prevention and Rehabilitation. 2008;15:397-401. .